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Abstract 
               Reaction of 1,3-propanediol with the achiral spermine-bridged cyclophosphazene 1 
at various molar ratios in THF gives a number of spiro-and ansa-derivatives that exhibit 
different stereogenic properties, viz. racemic, meso or achiral forms.  As expected, spiro forms 
are preferred (giving mono-, di-, tri- and tetra-substitution), although significant amounts of 
mono- and di-substituted ansa derivatives also occur.  A number of new structures have been 
characterized by NMR spectroscopy and X-ray crystallography in this work; mono-spiro 2, 
di-mono-ansa 6 and di-spiro/mono-ansa 8.  The mono-ansa compound 3 was observed in 
solution by NMR spectroscopy but no evidence was found for the monospiro/monoansa 5, a 
necessary precursor of compound 8.  The tri-spiro derivative 7 has been isolated and 
characterized by 31P NMR spectroscopy, whereas the structures of the di-monospiro 4 (meso) 
and tetra-spiro 9 have been characterized previously.  The stereogenic properties of many of 
the products have been confirmed by X-ray crystallography and/or by 31P NMR spectroscopy 
on addition of the chiral solvating agent, (S)-(+)-2,2,2-trifluoro-1-(9-anthryl)ethanol.  
Although the starting compound 1 is achiral, it is found that unsymmetrically-substituted 
derivatives with 1,3-propanediol give racemic mixtures for the mono-spiro 2 and tri-spiro 7 
derivatives, whereas symmetrically-substituted derivatives such as di-mono-ansa 6 and di-
spiro/mono-ansa 8 are meso.  It is found that care must taken in interpreting the 'splitting' of 
31P NMR signals on addition of CSA in terms of 'chirality' of molecules, because some meso 
compounds give false positive results due to changes from A2X-like to A2B or ABX spin 
systems. 
 
Keywords:  Cyclophosphazene derivatives, Stereogenicity, NMR, CSA (chiral solvating 
agent), X-ray crystallography 
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1. Introduction 
Tetra-coordinated phosphorus atoms in cyclophosphazenes are pentavalent and 
potential stereocentres.  Although the possibility of optical isomerism in cyclophosphazene 
derivatives, [(NPXY)n n=3,4] was first discussed many years ago [1], chiral properties of 
molecules have only recently been elucidated [2-5] and used to investigate reaction 
mechanisms [6, 7].  The spermine-bridged cyclophosphazene compound 1 has been prepared 
previously [8] by reaction of cyclotriphosphazene with the tetrafunctional amine, spermine.  
Compound 1 is achiral because the substitution pattern of each cyclophosphazene ring is the 
same and each cyclophosphazene ring has a plane of symmetry.  However, singly-bridged 
analogues with gem disubstituted cyclophosphazene rings (e.g. 4) exhibit stereoisomerism [3], 
because the three phosphorus atoms of each cyclophosphazene ring have different substitution 
patterns and those that are part of the bridge, >P(N-spiro), are stereogenic, i.e. there are R and 
S forms.  It was shown that spermine-bridged compounds such as 4 are diastereoisomeric and 
exist in 1:1 mixtures of meso (RS/SR) and racemic (RR/SS) forms [3].  Compound 4 was 
synthesised by the reaction at room temperature of 1,3-propanediol with 1 and, although a 
second compound was reported as the tri-spiro derivative, it was not characterized [3];  this 
compound is expected to be chiral and to exist as a racemic mixture.   
Reaction of 1,3-propanediol with compound 1 could, in principle, give rise to a number of 
different derivatives; if only one functional group of the diol is used, this would give open 
chain forms, whilst utilisation of both functional groups of the diol can give rise to spiro, ansa 
and bridged derivatives.  Reaction of N3P3Cl6 with ethane-, 1,3-propane- and 1,4-butane-diols 
(in the presence of pyridine to neutralise the hydrochloride formed) predominantly gave spiro 
derivatives for all three diols, whereas ansa derivatives were rare products obtained only in 
small yields [9].  A bridged derivative was observed as a minor product with butanediol, 
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indicating that chain length was a contributing factor in determining derivative-type [9].  It 
was also found that ansa-derivatives may be formed using sodium salts of diols as reagents in 
polar solvents such as THF [10].  The spiro- and ansa-derivatives of 1 should exhibit a range 
of stereogenic properties (achiral, meso, racemic, diastereoisomeric).  The purpose of the 
present work is to investigate the reaction of the sodium derivative of 1,3-propanediol with 
compound 1 in THF under different reaction conditions, to characterize the structures and 
stereogenic properties of the products and to show how widespread the question of chirality 
should be considered in cyclophosphazene chemistry. 
2. Experimental  
2.1. Materials 
Hexachlorocyclotriphosphazene (Otsuka Chemical Co., Ltd) was purified prior to use 
by fractional crystallisation from hexane.  The following chemicals were obtained from 
Merck; spermine (≥ 97.0%), diethyl ether, dichloromethane, benzene, n-hexane, 1,3-
propanediol (≥ 99.0%), silica gel 60, sodium hydride (60% oil suspension), tetrahydrofuran, 
ethyl acetate, chloroform and n-heptane.  The deuterated solvents for NMR spectroscopy were 
obtained from Apollo Scientific (toluene-d8, CDCl3) and the chiral solvating agent, (S)-(+)-
2,2,2-trifluoro-1-(9-anthryl)ethanol, was obtained from Aldrich Chemical Co.   
2.2. Measurements 
Elemental analyses were obtained using a Carlo Erba 1106 Instrument.  Mass 
spectrometric measurements were recorded on a VG Zab Spec GC-MS spectrometer using the 
fast atom bombardment (FAB) method (35 kV) with MNBA as the matrix; 35Cl values were 
used for calculated masses.  Analytical Thin Layer Chromatography (TLC) was performed on 
Merck silica gel plates (Merck Kieselgel 60, 0.25 mm thickness) with F254 indicator.  Column 
chromatography was performed on silica gel (Merck 60, 230-400 mesh; for 3g. crude mixture, 
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100g. silica gel was used in a column of 3 cm in diameter and 60 cm in length).  1H and 31P 
NMR spectra were recorded in CDCl3 or toluene-d8 solutions on a Bruker DRX 500 MHz 
spectrometer using TMS as an internal reference for 1H and 85% H3PO4 as an external 
reference for 31P.  For all new compounds both proton-coupled and proton-decoupled 31P 
NMR spectra were recorded.  Experiments involving the chiral solvating agent (CSA) were 
performed by addition of small aliquots of a dilute solution of CSA in the solvent used for 
NMR spectroscopy and the 31P NMR spectrum recorded at each addition.   
2.3. Synthesis 
Reaction of the sodium derivative of 1,3-propanediol with compound 1 in THF at different 
molar ratios gave a number of spiro and ansa derivatives as summarized in Scheme 1.  
                                                      Scheme 1 about here 
2.3.1.   4:1 mole ratio.  1,3-Propanediol (0.4g, 5.3mmol) and previously prepared [8] 
compound 1 (1g, 1.33mmol) were dissolved in 50mL of dry THF in a 250mL three-necked 
round-bottomed flask.  The reaction mixture was cooled in an ice-bath and NaH (60% oil 
suspension, 0.42g, 10.6mmol) in 50mL of dry THF was added under an argon atmosphere.  
The reaction mixture was stirred for 21 h at room temperature and the reaction followed to 
completion by TLC on silica gel plates using CHCl3:ethyl acetate (3:1) as the solvent system.  
The reaction mixture was filtered to remove the sodium chloride formed, the THF was 
removed under reduced pressure and the resulting white solid subjected to column 
chromatography using CHCl3:ethyl acetate(3:1) as eluent.  Two fractions were obtained and 
isolated as white powders and recrystallised from chloroform:hexane (1:1).  The first fraction 
is the dispiro-monoansa compound, 8, (yield: 0.29 g, 25%, mpt. 147-149oC; isolated as a 
chloroform adduct)  Found: C, 27.02; H, 4.20; N, 15.12 (M+H)+ , 761. C20H41Cl5N10P6O6 
requires: C, 27.27; H, 4.69; N, 15.90 (M+, 761.34).  The second fraction is the tetraspiro-
derivative, 9, whose NMR spectral data [11] and X-ray structure [12] have been characterized 
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previously (yield: 0.33 g. 32%, mpt. >250oC)  Found: C, 34.35; H, 6.2; N, 17.68. (M+H)+ , 
764. C22H46N10O8P6 requires: C, 34.56; H, 6.06; N, 18.32 M+, 764.52. 
2.3.2.  3:1 mole ratio.  1,3-Propanediol (0.9g, 11.95mmol) and previously prepared [8] 
compound 1 (3g, 3.98mmol) were dissolved in 200mL of dry THF in a 500mL three-necked 
round-bottomed flask.  The reaction mixture was cooled in an ice-bath and NaH (60% oil 
suspension, 0.95g, 23.9mmol) in 50mL of dry THF was added under an argon atmosphere.  
The reaction mixture was stirred for 24 h at room temperature and was followed by TLC on 
silica gel plates using THF:CH2Cl2 (5:2).  The reaction mixture was filtered to remove the 
sodium chloride formed, the THF was removed under reduced pressure and the resulting 
white solid subjected to column chromatography using THF:CH2Cl2 (5:2) as eluent.  Two 
fractions were obtained; the first fraction was isolated as a white powder (yield 0.22 g, 7.3%), 
(mpt. 84-90 oC) and characterized as the tri-spiro compound, 7. Found: C, 30.48; H, 5.14; N, 
17.95%; (M+H)+, 761.  C19H40Cl2N10O6P6 requires: C, 30.00; H, 5.30; N, 18.40 % ; M+, 760.  
1H NMR, CDCl3, 298K:  OCH2 signals at 4.52m, 2H and 4.4m, 10H; 3.23m, 4H, NCH2; 
3.1m, 4H, NCH2; 2.8m 4H, NHCH2; 2.5, broad triplet, 2H, NH; O-spiro, N-spiro and bridge 
CCH2 signals at 2.1m, 4H; 1.9m, 4H; 1.7, 8H.  The second fraction was isolated as a white 
powder (yield: 0.5g, 16.5%) (mpt. 147-149oC), re-crystallized from 
CH2Cl2:THF:Hexane(1:2:1) and characterized as the dispiro-monoansa compound, 8. Found: 
C, 29.30; H, 5.90; N, 17.68. (M+H)+, 760.8. C19H40Cl2N10O6P6 requires: C, 29.97; H, 5.30; N, 
18.40  M+, 760.  
2.3.3. 2:1 mole ratio.  1,3-Propanediol (1.06 g, 13.2 mmol) and previously prepared [8] 
compound 1 (5g, 6.6 mmol) were dissolved in 140 mL of dry THF in a 500 mL three-necked 
round-bottomed flask.  The reaction mixture was cooled in an ice-bath and NaH (60% oil 
suspension, 1.056 g, 26.4 mmol) in 100 mL of dry THF was quickly added under an argon 
atmosphere.  The reaction was stirred for 23 h at room temperature and was followed by TLC 
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on silica gel plates using CH2Cl2:ethyl acetate (6:1).  The reaction mixture was filtered to 
remove NaCl formed, the THF was removed under reduced pressure and the resulting white 
solid subjected to column chromatography using CH2Cl2:ethyl acetate (6:1).  Two fractions 
were obtained.  The first fraction has been characterized previously as the di-monospiro 
derivative 4 (isomer mixture, mpt. 210-216oC) [3] and the meso form characterized by X-ray 
crystallography [11].  The second major fraction was isolated as a white powder, re-
crystallized from dichloromethane:hexane (1:1) and characterized as the di-monoansa 
derivative 6 (yield: 0.4 g, 8%) (mpt. >250oC decomposition).  Found: C, 25.91; H, 4.08; N, 
17.88. (M+H)+ , 757 C16H34Cl4N10O4P6 requires: C, 25.35; H, 4.52; N, 18.47 M+, 756.  1H 
NMR, CDCl3, 298K:  4.48m, 4H, OCH2 signals; 4.21m, 4H, OCH2 signals; 3.23m, 4H, 
NCH2; 3.13m, 4H, NCH2; 2.92m 4H, NHCH2; ansa CCH2 signals at 2.2m, 2H and 1.9m, 2H; 
spiro and bridge CCH2 signals at 1.75m, 4H and 1.68m, 4H. 
2.3.4.  0.75:1 mole ratio:  1,3-Propanediol (0.25 g, 3.2 mmol) and previously prepared [8] 
compound 1 (3.3 g, 4.3 mmol) were dissolved in 150 mL of dry THF in a 500 mL three-
necked round-bottomed flask.  The reaction mixture was cooled in an ice-bath and NaH (60% 
oil suspension, 0.26g, 6.4 mmol) in 50 mL of dry THF was quickly added under an argon 
atmosphere.  The reaction was stirred for 24 h at room temperature and was followed by TLC 
on silica gel plates using CH2Cl2-ethyl acetate (1:2) as eluent.  The reaction mixture was 
filtered to remove the sodium chloride, the THF was removed under reduced pressure and the 
resulting white solid subjected to column chromatography using CH2Cl2:ethyl acetate (1:2).  
Two fractions were obtained, the first is the starting compound 1 [8], isolated as a white 
powder (recovery of starting material: 0.16 g, 5%) whose 1H NMR has not been previously 
reported in detail.  1H NMR, CDCl3, 298K: 3.24m, 4H, NCH2; 3.14m, 4H, NCH2; 2.84m 4H, 
NHCH2; 2.67 broad quartet, 2H, NH; spiro and bridge CCH2 signals at 1.82m, 4H and 1.56m, 
4H.  The second fraction was also isolated as a white powder (yield: 0.45 g, 14 %), (mpt. 150-
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151oC), recrystallised from CH2Cl2 :hexane:ethyl acetate (2:1:1) and characterized as the 
mono-spiro compound 2.  Found: C, 19.90; H, 3.50; N, 18.40 (M+H)+, 754.9. 
C13H28Cl6N10O2P6 requires: C, 20.68; H, 3.74; N, 18.55 M+, 754.  1H NMR, CDCl3, 298K:  
4.53m 2H, OCH2 signals; 4.37m 2H, OCH2 signals; 3.1 – 3.3m, 8H, NCH2; 2.8-2.9m, 4H, 
NHCH2; 2.64, broad quartet, 1H, NH;  2.52, broad triplet, 1H, NH; CCH2 signals at 2.14m, 
1H; 1.75-1.9m, 5H; 1.6m, 4H.  1H NMR, toluene-d8, 298K:  4.53m 2H, OCH2 signals; 4.37m 
2H, OCH2 signals; 3.25m 4H, NCH2; 3.1 – 3.3m 8H, NCH2; 3.15m 4H, NCH2; 2.85m 4H, 
NHCH2; 2.64, broad quartet, 1H, NH;  2.52, broad triplet, 1H, NH; CCH2 signals at 2.14m, 
1H; 1.75-1.9m, 5H; 1.6m, 4H. 
2.4. X-ray crystallography.  
Intensity data were recorded at low temperature (120 K) on a Nonius KappaCCD 
diffractometer situated at the window of an FR591 rotating anode generator, driven by 
COLLECT [13] and DENZO [14] software.  Details of data collection and refinement are 
given in Table 1.  All structures were determined using the direct methods procedure in 
SHELXS-97 [15] and refined by full-matrix least squares on F2 using SHELXL-97 [16]. The 
structure of 8 exhibits a solvent of crystallisation (CHCl3) and some disorder in the central 
chain (atom C8 / C8'), which is modelled at 55:45 %.  Full details of data collection and 
structure determination have been deposited with the Cambridge Crystallographic Data 
Centre (CCDC). 
                                                                       Table 1 about here 
3. Results and discussion 
Formation of spiro- and ansa-substituted spermine-bridged cyclotriphosphazenes  
Reaction of the sodium derivative of 1,3-propanediol with the spermine-bridged 
cyclophosphazene 1 in different mole ratios (4:1, 3:1, 2:1, 0.75:1) in THF gave a number of 
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spiro- and ansa-substituted derivatives as shown in Scheme 1.  In order to investigate all 
major reaction products, the crude reaction mixtures were routinely characterized by proton-
decoupled 31P NMR, as well as all major fractions isolated.  Reaction of 1,3-propanediol with 
1 in a 4:1 mole ratio for 21 h at room temperature gave the fully substituted dispiro-monoansa 
8 and tetra-spiro 9 derivatives, whereas reaction at a 3:1 mole ratio under the same solution 
conditions gave the tri-spiro derivative 7 and the isomeric compound 8.  Reaction of 1,3-
propanediol with 1 in a 2:1 mole ratio for 23h at room temperature gave the di-monospiro 4 
and di-monoansa 6 derivatives and reaction at a 0.75:1 mole ratio for 24 h at room 
temperature gave the mono-spiro 2 and mono-ansa 3 derivative.  It is obvious from Scheme 1 
that the mono-spiro derivative 2 is the precursor of the spiro-substituted compounds 4 (di), 7 
(tri), and 9 (tetra), and the mono-ansa derivative 3 is a precursor of 6 (di-mono-ansa) and 8 
(di-spiro/mono-ansa).  The mono-spiro/mono-ansa derivative 5 could be formed from either 
the mono-spiro 2 or the mono-ansa compound 3 and the dispiro/mono-ansa derivative 8 
should have compound 5 as precursor.  Attempts were made to prepare the mono-spiro/mono-
ansa compound 5, but amounts in the reaction mixtures were too small to isolate and 
characterize independently.  Each of the new compounds 2, 6 and 8 was characterised by X-
ray crystallography and by elemental analysis, MS and 31P NMR using both proton-decoupled 
and proton-coupled spectra.  Although crystals suitable for X-ray crystallography could not be 
obtained for 3 and 7, these compounds were characterized by 31P NMR spectroscopy.  The 31P 
NMR results for all of the compounds are summarised in Table 2.   
                                                                    Table 2 about here 
 X-ray crystal structures of the spiro- and ansa-derivatives (2, 6, 8) of the spermine-
bridged compound, 1 
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The molecular structures of compounds 2, 6 and 8 are shown in Figures 1-3, respectively.  
The crystal structures of the meso form of the di-mono-spiro compound 4 [11] and the tetra-
spiro compound 9 [12] have been published previously.   
                                                    Figures 1-3, about here 
Compound 2.  The molecular structure of the mono-spiro compound 2 in Figure 1 depicts an 
asymmetrically-bridged molecule, in which one of the cyclophosphazene moieties is 
unsubstituted and the other exhibits a mono-spiro substituted phosphorus site.  Both N3P3 
rings of compound 2 are nearly planar, with the maximum deviations from the mean ring 
plane being 0.092Å (atom P2) and 0.104Å (atom N8) for rings 1 (spiro derivative) and 2 (un-
substituted), respectively.  Ring 2 exhibits slight ring compression with a shortened non-
bonded separation between ring phosphorus atoms of 2.699Å (P4…P5), whereas the expected 
distance surveyed from the Cambridge Structural Database [17] is about 2.78Å.  The 
spermine bridge introduces chirality to the molecule at the phosphorus sites linking it to the 
unsymmetrically-substituted cyclophosphazene ring and is found to be S for atom P3.  The 
molecule is chiral and exists as a racemate.  The relative conformation of the two 
cyclophosphazene rings around the tetra-methylene bridge is neither pure syn nor anti, but is 
approximately 2/3 of the way towards the latter, forming an angle of 59.5° between the two 
ring planes.  Hydrogen-bonding occurs at the N3P3 moiety containing the spiro-propanedioxy 
group and gives rise to discreet dimers through an N-H…N interaction (N4-H4N…N2 D…A 
distance = 3.282Å).  Eight-membered hydrogen-bonded rings are formed, in which the two 
heavy atom distances are equal at 3.282Å and result in a twist-boat conformation.  At 
distances >3.4Å a more complex hydrogen-bonded motif links the molecules into an infinite 
layer structure.  
Compound 6.  The molecular structure of the di-monoansa compound 6 in Figure 2 is that of a 
symmetrically-bridged spermine derivative, where the cyclophosphazene substituents both 
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possess a propanedioxy ansa-bridged moiety, giving rise to a centrosymmetric structure with 
the centre of inversion about the central C-C bond of the spermine bridge.  The 
cyclophosphazene ring is heavily distorted, as observed in similar ansa-bridged examples 
[18], with a maximum deviation from the mean ring plane of 0.328Å for the nitrogen atom 
(N1) bridged by the ansa group.  This give rise to compression of the cyclophosphazene ring, 
where the non bonded P…P separation between atoms P1 and P2 is 2.615Å.  The ansa bridge 
introduces chirality into the molecule such that P1 = R and P2 = S, with the symmetry 
generated partners having the opposite chirality due to the inversion centre resulting in 6 
being a meso compound.  As a result of the centrosymmetric nature of the structure, the two 
cyclophosphazene rings are disposed exactly syn to each other with respect to the spermine 
bridge.  The supramolecular structure is that of a hydrogen bonded dimer, where an NH of the 
spermine group interacts with a cyclophosphazene ring nitrogen in a head to tail fashion (N4-
H4N…N2 D…A distance = 3.154Å).  Longer range interactions arrange these dimers into an 
infinite sheet structure.  This arrangement is similar to that of the hydrogen bonded structure 
of 2, apart from the conformation of the eight-membered hydrogen-bonded ring, which forms 
a slightly twisted chair in the crystal structure of 6.  
 Compound 8.  The molecular structure of the dispiro-monoansa compound 8 in Figure 3 is 
that of a spermine moiety bridging two asymmetrically-substituted cyclophosphazene rings, 
one with an ansa propanedioxy substituent and the other with two spiro groups.  As in the 
structure of 6 the cyclophosphazene ring of the ansa-bridged moiety is highly distorted, with 
the ansa-bridged cyclophosphazene ring nitrogen (N1) positioned out of the mean ring plane 
by 0.31Å and with the compressed non bonded P…P separation between atoms P1 and P2 
being 2.627Å.  On the other hand, the di spiro substituted cyclophosphazene ring is nearly 
planar with a maximum deviation from the mean ring plane of 0.117Å for atom P6.  Although 
the ansa bridge introduces chirality into the molecule such that P1 = S and P2 = R, overall the 
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molecule is meso.  The relative conformation of the two cyclophosphazene rings around the 
tetra-methylene bridge is in an approximate syn conformation with an angle of 26.7° between 
the two ring planes.  As observed in structures 2 and 6 the hydrogen bonded structure of 8 is 
that of a dimer, formed between the NH hydrogen of the spermine group and a 
cyclophosphazene ring nitrogen, with the separation between donor and acceptor atoms being 
3.039 and 3.140Å.  These unequal distances result in a saddle-shape hydrogen-bond ring 
conformation.  The hydrogen-bonded motifs occur at both ends of these molecules, thus 
forming an infinite chain.   
 
Characterization of the chiral configurational properties of compounds 2 and 7 by 31P 
NMR on addition of a chiral solvating agent, (S)-(+)-2,2,2-trifluoro-1-(9-anthryl)ethanol 
It is found that one set of proton-decoupled 31P NMR signals are observed for compounds 2, 
3, 6-9 whereas two sets of closely-spaced signals are observed for the di-monospiro 
compound 4.  The latter two sets of signals correspond to the meso and racemic forms of 
compound 4 as shown previously for analogous spermine-bridged compounds [3].  On 
addition of chiral solvating agent [19], (S)-(+)-2,2,2-trifluoro-1-(9-anthryl)ethanol, CSA, in 
CDCl3 or toluene-d8 solution some of the 31P NMR signals for compounds 2 and 7 separate 
into two signals of equal intensity characteristic of racemic mixtures.  X-ray crystallography 
has shown that compound 2 is chiral and exists as a racemate, whereas crystals of compound 
7 suitable for X-ray analysis could not be obtained.  As an example, the stereogenic properties 
of the tri-spiro compound 7 are demonstrated by NMR spectroscopy in Figure 4.  The proton-
decoupled 31P NMR spectrum of compound 7 in toluene-d8 shown in Fig.4(a) consists of five 
multiplets corresponding to an AMX spin system for the mono-spiro substituted 
cyclophosphazene ring [signals expanded in Fig.4(b)] and an A2X spin system for the di-
spiro-substituted ring.  Assignment of the 31P NMR signals of the AMX part of compound 7 
 13
to >PCl2, >P(N-spiro) and >P(O-spiro) groups was made by comparison of proton-coupled 
(not shown) and proton-decoupled spectra, whereas assignment of the A2X spin system to 
>P(N-spiro) and >P(O-spiro) follows simply from the triplet and doublet signals, respectively.  
Addition of CSA to the solution of compound 7 causes changes in chemical shifts of all 
signals indicating complexation and, as shown in Fig.4(c), it also causes splitting of all peaks 
for the AMX part of the spectrum, which is consistent with compound 7 being chiral and 
existing as a racemate.  
                                                                        Figure 4  about here 
The effect of addition of CSA on chemical shifts of all the spiro and ansa derivatives in either 
CDCl3 or toluene-d8, as appropriate, is summarised in Table 3 at a molar ratio of 
CSA:compound of 10:1.  It is found that changes in chemical shifts occur for all compounds 
indicating complexation with CSA, whether the compounds are racemic, meso or achiral.  
Normally there is a differential effect on signals probably reflecting the mode of 
complexation of CSA with the compound and the proximity of the CSA to each of the groups 
in the complex.  For example, it is found that the effect of CSA on the P(N-spiro) group of all 
compounds is negative (signals move to low frequency), whereas the effect on the PCl2 and 
P(O-spiro) groups is smaller and can be either positive or negative.  It is likely that the NH 
moiety of the P(N-spiro) group of all compounds is a major site of complexation of CSA, in 
line with previous work on many different compounds containing NH and OH groups [19].  It 
is also found that the effect of CSA on chemical shifts of compound 2 is greater for solutions 
in toluene-d8 compared with CDCl3 (Table 3), which prompted the choice of toluene-d8 for 
NMR investigation of the stereogenic properties of compound 7 in solution. 
Table 3  about here 
It is found that care must be taken in interpreting the stereogenic properties of compounds by 
NMR spectroscopy on addition of CSA (or CSR) to the solution, because there are many 
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cases of false positive results.  It has already been shown [11] that the 31P NMR signals of 
meso forms of spermine-bridged compounds such as compound 4 may exhibit doubling of 
peaks on addition of CSA.  Another ‘false positive effect’ may be observed for 31P NMR 
signals of meso compounds because the changes in chemical shifts on addition of CSA cause 
the spectra to change from A2X-like to an A2B spin system; this was observed for the 'doublet' 
signals of the >P(OR)Cl group of meso compound 6, in which each resonance split into two 
signals of unequal and small separation (e.g. 1.8 and 2.4 Hz at an 18:1 mole ratio) that may be 
due to an A2B (or even ABX) spin system rather than as a result of a stereogenic effect (Table 
3).  An analogous, but larger, effect has also been observed for compound 8 in this work 
(Table 3).  On addition of CSA the 'doublet' signals of the >P(OR)Cl groups of meso 
compound 8 split into two signals of unequal and small separation (e.g. 3.1 and 3.8 Hz at a 
17:1 mole ratio) that could be fitted as an ABX spin system, but not an A2B spin system, 
which probably indicates another example of the 'anomalous meso effect' (as in ref. [11]) 
4. Conclusions 
The chiral configurational isomers of spiro- and ansa-substituted spermine-bridged 
cyclophosphazene compounds have been investigated by X-ray crystallography and 31P NMR 
spectroscopy.  The symmetry of spermine-bridged cyclophosphazene compound 1 indicates 
that it is achiral, though it contains two potential homotopic stereogenic centres [>P(N-spiro) 
moiety of the two N3P3 units], which could lead to chiral compounds if substitution of the 
cyclophosphazene rings leads to asymmetry in the molecule.  Substitution with 1,3-
propanediol gives a series of spiro- and ansa-substituted spermine-bridged cyclo-phosphazene 
compounds; unsymmetrically-substituted bridged compounds are found to be chiral and exist 
as racemic mixtures of R and S forms, viz. mono-spiro 2 and tri-spiro 7, whereas 
symmetrically-substituted bridged compounds may be meso, such as the di-mono-ansa 6 and 
di-spiro-mono-ansa 8 derivatives, or achiral, such as the tetra-spiro derivative 9.  Using X-ray 
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crystallography and 31P NMR spectroscopy with addition of a chiral solvating agent, (S)-(+)-
2,2,2-trifluoro-1-(9-anthryl)ethanol, it has been shown previously that the di-mono-spiro 
derivative 4 exists as a 1:1 mixture of meso and racemic forms [11].  In this work, X-ray 
crystallographic studies have provided definitive proof of the stereogenic properties of 
compounds 2, 6 and 8, which have been confirmed using 31P NMR spectroscopy and addition 
of a chiral solvating agent.  In addition, the stereogenic properties of chiral compounds 2 and 
7 have been elucidated using 31P NMR spectroscopy and addition of CSA.  The work 
demonstrates that derivatives of bridged cyclophosphazene compounds exhibit a range of 
stereogenic properties and that the question of chirality is an important consideration in 
cyclophosphazene chemistry. 
 
Supplementary data are available from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK 
on request, quoting deposition numbers CCDC 27630 – 276732 for compounds 2, 6 and 8, 
respectively. 
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Table 1  X-ray crystallographic data 
 2 6 8a
Empirical formula C13H28Cl6N10O2P6 C16H34Cl4N10O4P6 C20H41Cl5N10O6P6
Formula weight 754.97 758.15 880.70 
Crystal system Monoclinic Triclinic Orthorhombic 
Space group P21/c P-1 Pna21
a (Å) 9.5842(2) 8.5849(17) 15.229(3) 
b (Å) 12.5090(2) 9.5425(19) 26.120(5) 
c (Å) 25.3979(5) 15.6271(19) 9.2683(19) 
α (°) 90 84.46(3) 90 
β  (°) 101.1840(10) 84.63(3) 90 
γ (°) 90 75.67(3) 90 
Volume (Å3) 2987.10(10) 758.6(3) 3686.7(13) 
Z 4 1 4 
Density (calc) (Mg/m3) 1.679 1.660 1.587 
Absorption coefficient 
(mm-1) 
0.931 0.752 0.705 
F(000) 1536 390 1816 
Crystal size (mm) 0.55 × 0.42 × 0.10 0.28 × 0.2 × 0.05 0.45 x 0.14 x 0.12 
θmax (°) 27.50 27.42 27.48 
Reflections collected 34810 11470 24873 
Independent reflections 
(I>2σI) 
6836 3392 7818 
R(int) 0.0779 0.0724 0.0723 
Final R indices F2>2σF2 R1 = 0.0607 
wR2 = 0.1463 
R1 = 0.0396 
wR2 = 0.1013 
R1 = 0.0432 
wR2 = 0.0973 
Δρ max / min  (eÅ-3) 1.103 / −0.814 0.407 / −0.702 0.584 / −0.389 
     a Isolated as a 1:1 adduct with chloroform 
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Table 2.  31P NMR parameters of spiro- and ansa-forms of 1,3-propanedioxy-substituted  
spermine-bridged cyclophosphazenesa
                Chemical shifts / ppm                   2J(PP) / Hz Compound: 
ring config.b >PCl2 >P(Nspiro) >P(Ospiro) >P(OR)Cl 1,2 1,3 2,3 2,4 
  1 2 3 4     
1c  22.1 10.4   40.5    
2  22.1 10.2   40.4    
 sp 25.0 15.5 9.0  41.1 68.0 63.6  
2d  21.5 11.2   40.3    
 sp 23.5 16.8 9.4  38.0 65.5 68.2  
3  22.0 10.2   40.4    
 an  16.8  30.8    46.5 
4e,f   r sp 25.01 15.45 9.01  40.5 68.7 63.4  
      m sp 25.0 15.42 8.99  40.5 68.7 63.4  
6 an  16.4  30.4    46.3 
7 sp 25.1 15.5 9.1  40.2 68.8 63.1  
 di-sp  19.8 14.6    57.9  
7d sp 23.5 16.9 9.5  36.6 66.8. 68.0  
 di-sp  20.8 14.9    59.9  
8 an  16.4  30.3    46.3 
 di-sp  19.4 14.1    58.2  
9e di-sp  19.8 14.6    58.0  
          
 
a 202.45 MHz 31P NMR measurements in CDCl3 solutions at 298K.  Chemical shifts referenced to external 
85% H3PO4
b  Abbreviations: sp = spiro, an = ansa; r = racemate, m = meso 
c  Data taken from ref.[3]  
d  Data on toluene-d8 at 298K.  It is noted that, in comparison of the 31P NMR spectra of the mono-spiro 
substituted ring of both compounds 2 and 7 in toluene-d8 and CDCl3 solutions, changes occur not only in 
chemical shifts (as expected) but also in 2J(PP) values. 
e  Data taken from ref.[11]  
f  Unequivocal assignment of meso (m) and racemic (r) forms resulted from characterization of the meso 
form of the diastereoisomer by X-ray crystallography [11]. 
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Table 3.  Effect of addition of CSA on 31P NMR chemical shifts of spiro- and ansa-forms of 
1,3-propanedioxy-substituted spermine-bridged cyclophosphazenes 
Compound               Change in chemical shifts/ppbb Separation of signals/ppb 
No.       Typea   
(i)  CSA with symmetrically substituted spermine-bridged compounds at 10:1 mole ratio 
   X or X2 >PX2 >P(bridge) >PCl2 >PX2 >P(bridge) >PCl2
1c  ach Cl  -21 37  - - 
4d s-s r O(CH2)3O 16 -140 26 13 53 25 
 s-s m O(CH2)3O 14 -145 28 15 56 27 
9c ss-ss ach. O(CH2)3O -48 -164   -  
6 a-a m Cl/{O(CH2)3O]0.5 11 -158  e -  
  
(ii) CSA with unsymmetrically substituted spermine-bridged compounds at a 10:1 mole ratio 
   X or X2  >PX2 >P(bridge) >PCl2 >PX2 >P(bridge) >PCl2
2   Cl  -5 11  f 0 g
 s r O(CH2)3O -9 -25 4   5 h
2i   Cl  -70 70 0   
 s r O(CH2)3O 105 -470 110 40  70 
7i ss  O(CH2)3O -223 -1020  f f  
 s r O(CH2)3O 74 -325 65 47 80 10 
8 ss m O(CH2)3O -100 -320     
 a  Cl/[O(CH2)3O]0.5 20 -184  j -  
a  s = spiro, a = ansa; ach = achiral, m = meso, r = racemate 
b  Δδ = (δCSA-δorig.); Δδ positive for high frequency shifts on addition of CSA in CDCl3 unless otherwise noted. 
c  Data from ref. [11] 
d  Although compound 4 was known to exhibit meso and racemic forms in ref. [3], the effect of CSA (or CSR) 
was not reported.  The effect of CSA on the meso form was reported in ref. [11]  
e  On addition of CSA the 'doublet' signals of the >P(OR)Cl group of meso compound 6 split into two signals of 
unequal and small separation (e.g. 1.8 and 2.4 Hz at an 18:1 mole ratio) due to the A2B spin system rather than 
as a result of a stereogenic effect; cf. ref. [11]. 
f  signals are broad and mask any effect of CSA  
g   signals are sharp but no effect is observed up to 84:1 mole ratio. 
h  Approximate value derived by extrapolation of effect from higher mole ratios (between 46:1 to 84:1)      
i   In toluene-d8 solution              
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j  On addition of CSA the 'doublet' signals of the >P(OR)Cl group of meso compound 8 split into two signals of 
unequal and small separation (e.g. 3.1 and 3.8 Hz at a 17:1 mole ratio) that could be fitted as an ABX spin 
system rather than an A2B spin system, which probably indicates another type of example of the 'anomalous 
meso effect' (cf. ref. [11])  
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Figure 1.   Crystal structure of the mono-spiro compound 2. 
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Figure 2.   Crystal structure of the di-mono-ansa compound 6 
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Figure 3.   Crystal structure of the di-spiro/mono-ansa compound 8, with disorder (about atom 
C8) and the CHCl3 solvent molecule removed for clarity. 
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Figure 4.  202.45 MHz proton-decoupled 31P NMR spectra of the tri-spiro substituted 
compound 7 in toluene-d8 solution at 298K   (a)  The AMX spin system corresponds to the 
mono-spiro substituted ring and the A2X spin system corresponds to the di-spiro substituted 
ring.  (b)  Expanded signals of the AMX spin system of the mono-spiro substituted ring.  (c)  
Addition of CSA causes each line of the AMX signals to split into two, corresponding to the 
two enantiomers. 
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Scheme 1†
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† Stereogenicity confirmed by X-ray (or by NMR + CSA) except for compounds with numbers in 
brackets 
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Graphical abstract 
 
Reaction of the achiral spermine-bridged cyclotriphosphazene compound (A-Z =Cl ) with 1,3-
propanediol at different molar ratios in THF gives various spiro- and ansa-derivatives with 
different stereogenic properties, i.e. racemates for unsymmetrically-substituted derivatives 
and meso, diastereoisomeric or achiral forms for symmetrical substitution. 
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